Showing 49-60 of 206 articles
A Swedish registry analysis found a higher relative stroke rate below the cohort's median birthweight, but it does not show that birthweight determines an adult's cardiovascular fate.
Vendor estimates across five states put initial Medicaid and SNAP eligibility-system changes at no less than $45.6 million.
Follow-up testing cleared Great Value dino nuggets after a false positive, while a separate Tops peeled-garlic recall over temperature control has been completed.
Donald Trump initiated a broad overhaul of pharmaceutical trade on April 3, 2026, by imposing 100% tariffs on imported brand-name medications.
Marketplace enrollees use Forms 1095-A and 8962 to compare advance premium tax credits with the amount allowed by their final 2025 household income.
The justices held that Colorado's law discriminated by viewpoint as applied to Kaley Chiles's talk therapy, then returned the case for strict scrutiny.
A UK survey found physiotherapy staffing below guidance in hospital and community stroke services as teams struggled to offer rehab five days a week.
Aberystwyth researchers will test whether intolerance of uncertainty is a distinct contributor to anxiety in autistic adults.
VCU Massey's IVMT-Rx-4 findings point to a prostate cancer bone-metastasis strategy, but the evidence remains preclinical and needs human safety and dosing data.
EPA's draft CCL 6 puts microplastics and pharmaceuticals on the drinking-water radar, but monitoring methods, health evidence and funding remain unresolved.
Eli Lilly's FDA-approved Foundayo gives obesity treatment a flexible oral GLP-1 option, but Novo Nordisk's Wegovy pill leads early prescriptions.
England recorded an estimated 1,504 heat-associated deaths in summer 2025, below a modelled estimate of 3,039, but the analysis could not establish why.